Procyon Corporation Logo

Procyon Corporation

PCYN

(1.2)
Stock Price

0,20 USD

-10.81% ROA

-14.39% ROE

-5.67x PER

Market Cap.

2.108.181,00 USD

16.19% DER

0% Yield

-6.84% NPM

Procyon Corporation Stock Analysis

Procyon Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Procyon Corporation Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.56x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a minimal amount of debt (19%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

4 ROE

The stock's ROE indicates a negative return (-1.91%) on shareholders' equity, suggesting poor financial performance.

5 ROA

The stock's ROA (-1.42%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

7 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (-46) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Procyon Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Procyon Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Buy

Procyon Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Procyon Corporation Revenue
Year Revenue Growth
1996 308.668
1997 215.561 -43.19%
1998 371.198 41.93%
1999 300.000 -23.73%
2000 702.855 57.32%
2001 1.146.799 38.71%
2002 1.358.278 15.57%
2003 1.645.759 17.47%
2004 2.024.776 18.72%
2005 2.198.261 7.89%
2006 2.313.345 4.97%
2007 2.536.577 8.8%
2008 2.562.704 1.02%
2009 2.365.647 -8.33%
2010 2.547.365 7.13%
2011 2.701.996 5.72%
2012 2.801.255 3.54%
2013 2.749.850 -1.87%
2014 2.838.959 3.14%
2015 2.771.705 -2.43%
2016 3.449.151 19.64%
2017 4.012.419 14.04%
2018 4.020.274 0.2%
2019 4.191.188 4.08%
2020 4.334.088 3.3%
2021 4.719.672 8.17%
2022 4.842.433 2.54%
2023 4.686.659 -3.32%
2024 4.794.156 2.24%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Procyon Corporation Research and Development Expenses
Year Research and Development Expenses Growth
1996 0
1997 0 0%
1998 48.122 100%
1999 0 0%
2000 36.625 100%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 2.170 100%
2014 21.177 89.75%
2015 22.825 7.22%
2016 20.040 -13.9%
2017 31.298 35.97%
2018 41.747 25.03%
2019 33.140 -25.97%
2020 23.093 -43.51%
2021 30.900 25.27%
2022 30.000 -3%
2023 30.600 1.96%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Procyon Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
1996 0
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 1.692.610 100%
2008 1.791.763 5.53%
2009 1.752.941 -2.21%
2010 1.822.536 3.82%
2011 1.769.779 -2.98%
2012 1.868.017 5.26%
2013 2.061.498 9.39%
2014 2.064.737 0.16%
2015 2.304.562 10.41%
2016 2.522.265 8.63%
2017 2.719.829 7.26%
2018 2.808.615 3.16%
2019 2.952.513 4.87%
2020 3.046.397 3.08%
2021 3.063.923 0.57%
2022 3.723.036 17.7%
2023 3.666.968 -1.53%
2024 4.078.228 10.08%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Procyon Corporation EBITDA
Year EBITDA Growth
1996 -513.156
1997 -691.658 25.81%
1998 -843.202 17.97%
1999 -600.000 -40.53%
2000 -302.913 -98.08%
2001 -682.081 55.59%
2002 -88.651 -669.4%
2003 89.362 199.2%
2004 238.637 62.55%
2005 277.503 14.01%
2006 381.153 27.19%
2007 279.706 -36.27%
2008 176.301 -58.65%
2009 203.924 13.55%
2010 217.687 6.32%
2011 373.789 41.76%
2012 267.202 -39.89%
2013 23.423 -1040.77%
2014 101.719 76.97%
2015 -303.419 133.52%
2016 235.537 228.82%
2017 77.513 -203.87%
2018 175.793 55.91%
2019 149.719 -17.42%
2020 171.420 12.66%
2021 490.314 65.04%
2022 -21.005 2434.27%
2023 134.421 115.63%
2024 -53.920 349.3%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Procyon Corporation Gross Profit
Year Gross Profit Growth
1996 218.070
1997 118.610 -83.85%
1998 189.948 37.56%
1999 200.000 5.03%
2000 574.936 65.21%
2001 881.738 34.8%
2002 1.095.639 19.52%
2003 1.281.940 14.53%
2004 1.560.020 17.83%
2005 1.666.761 6.4%
2006 1.793.456 7.06%
2007 1.936.402 7.38%
2008 1.932.241 -0.22%
2009 1.913.626 -0.97%
2010 2.004.572 4.54%
2011 2.105.104 4.78%
2012 2.099.383 -0.27%
2013 2.048.978 -2.46%
2014 2.130.084 3.81%
2015 1.963.200 -8.5%
2016 2.418.693 18.83%
2017 2.749.793 12.04%
2018 2.935.700 6.33%
2019 3.049.586 3.73%
2020 3.199.413 4.68%
2021 3.388.693 5.59%
2022 3.485.821 2.79%
2023 3.569.587 2.35%
2024 1.685.664 -111.76%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Procyon Corporation Net Profit
Year Net Profit Growth
1996 -519.393
1997 -697.311 25.51%
1998 -855.459 18.49%
1999 -600.000 -42.58%
2000 -318.005 -88.68%
2001 -686.686 53.69%
2002 -137.911 -397.92%
2003 32.006 530.89%
2004 258.058 87.6%
2005 314.839 18.03%
2006 342.229 8%
2007 498.380 31.33%
2008 793.181 37.17%
2009 24.675 -3114.51%
2010 122.773 79.9%
2011 192.896 36.35%
2012 128.500 -50.11%
2013 -104.302 223.2%
2014 23.608 541.81%
2015 -218.271 110.82%
2016 109.569 299.21%
2017 12.378 -785.19%
2018 -255.727 104.84%
2019 27.224 1039.34%
2020 111.658 75.62%
2021 694.349 83.92%
2022 -209.790 430.97%
2023 -50.245 -317.53%
2024 -411.152 87.78%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Procyon Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1996 0
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Procyon Corporation Free Cashflow
Year Free Cashflow Growth
1996 -485.294
1997 -652.736 25.65%
1998 -631.957 -3.29%
1999 -600.000 -5.33%
2000 -396.689 -51.25%
2001 -518.235 23.45%
2002 -226.305 -129%
2003 -38.436 -488.78%
2004 18.814 304.29%
2005 202.280 90.7%
2006 354.157 42.88%
2007 152.107 -132.83%
2008 116.260 -30.83%
2009 149.498 22.23%
2010 258.733 42.22%
2011 72.236 -258.18%
2012 423.911 82.96%
2013 -25.853 1739.7%
2014 -189.952 86.39%
2015 -458.549 58.58%
2016 -54.589 -740%
2017 163.704 133.35%
2018 39.772 -311.61%
2019 22.084 -80.09%
2020 175.728 87.43%
2021 214.334 18.01%
2022 -312.103 168.67%
2023 -34.672 -800.16%
2024 57.326 160.48%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Procyon Corporation Operating Cashflow
Year Operating Cashflow Growth
1996 -483.530
1997 -646.788 25.24%
1998 -624.824 -3.52%
1999 -600.000 -4.14%
2000 -380.995 -57.48%
2001 -485.580 21.54%
2002 -217.311 -123.45%
2003 -37.214 -483.95%
2004 87.545 142.51%
2005 211.998 58.7%
2006 363.209 41.63%
2007 206.495 -75.89%
2008 118.171 -74.74%
2009 160.829 26.52%
2010 267.306 39.83%
2011 129.089 -107.07%
2012 430.924 70.04%
2013 -13.383 3319.94%
2014 -179.494 92.54%
2015 -392.025 54.21%
2016 18.682 2198.41%
2017 199.560 90.64%
2018 86.499 -130.71%
2019 50.837 -70.15%
2020 198.772 74.42%
2021 279.500 28.88%
2022 -229.459 221.81%
2023 145.466 257.74%
2024 58.074 -150.48%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Procyon Corporation Capital Expenditure
Year Capital Expenditure Growth
1996 1.764
1997 5.948 70.34%
1998 7.133 16.61%
1999 0 0%
2000 15.694 100%
2001 32.655 51.94%
2002 8.994 -263.08%
2003 1.222 -636.01%
2004 68.731 98.22%
2005 9.718 -607.25%
2006 9.052 -7.36%
2007 54.388 83.36%
2008 1.911 -2746.05%
2009 11.331 83.13%
2010 8.573 -32.17%
2011 56.853 84.92%
2012 7.013 -710.68%
2013 12.470 43.76%
2014 10.458 -19.24%
2015 66.524 84.28%
2016 73.271 9.21%
2017 35.856 -104.35%
2018 46.727 23.26%
2019 28.753 -62.51%
2020 23.044 -24.77%
2021 65.166 64.64%
2022 82.644 21.15%
2023 180.138 54.12%
2024 748 -23982.62%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Procyon Corporation Equity
Year Equity Growth
1996 504.742
1997 476.581 -5.91%
1998 -247.678 292.42%
1999 -800.000 69.04%
2000 500.928 259.7%
2001 -185.758 369.67%
2002 -323.666 42.61%
2003 -220.898 -46.52%
2004 37.160 694.45%
2005 351.999 89.44%
2006 694.228 49.3%
2007 1.192.608 41.79%
2008 1.985.789 39.94%
2009 2.010.464 1.23%
2010 2.133.237 5.76%
2011 2.326.133 8.29%
2012 2.454.633 5.23%
2013 2.350.331 -4.44%
2014 2.373.939 0.99%
2015 2.155.668 -10.13%
2016 2.270.377 5.05%
2017 2.287.500 0.75%
2018 2.031.773 -12.59%
2019 2.058.997 1.32%
2020 2.163.716 4.84%
2021 2.950.978 26.68%
2022 2.667.954 -10.61%
2023 2.617.709 -1.92%
2024 2.249.314 -16.38%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Procyon Corporation Assets
Year Assets Growth
1996 564.350
1997 575.346 1.91%
1998 208.843 -175.49%
1999 200.000 -4.42%
2000 610.542 67.24%
2001 217.380 -180.86%
2002 259.870 16.35%
2003 381.475 31.88%
2004 503.371 24.22%
2005 628.893 19.96%
2006 911.159 30.98%
2007 1.902.392 52.1%
2008 2.679.682 29.01%
2009 2.722.239 1.56%
2010 2.869.887 5.14%
2011 2.949.723 2.71%
2012 2.918.553 -1.07%
2013 2.657.311 -9.83%
2014 2.628.268 -1.11%
2015 2.516.429 -4.44%
2016 3.118.972 19.32%
2017 2.729.811 -14.26%
2018 2.358.249 -15.76%
2019 2.434.932 3.15%
2020 2.821.641 13.71%
2021 4.242.329 33.49%
2022 3.802.497 -11.57%
2023 3.563.711 -6.7%
2024 3.454.268 -3.17%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Procyon Corporation Liabilities
Year Liabilities Growth
1996 59.608
1997 98.765 39.65%
1998 456.521 78.37%
1999 1.000.000 54.35%
2000 109.614 -812.29%
2001 403.138 72.81%
2002 583.536 30.91%
2003 602.373 3.13%
2004 466.211 -29.21%
2005 276.894 -68.37%
2006 216.931 -27.64%
2007 709.784 69.44%
2008 693.893 -2.29%
2009 711.775 2.51%
2010 736.650 3.38%
2011 623.590 -18.13%
2012 463.920 -34.42%
2013 306.980 -51.12%
2014 254.329 -20.7%
2015 360.761 29.5%
2016 848.595 57.49%
2017 442.311 -91.85%
2018 326.476 -35.48%
2019 375.935 13.16%
2020 657.925 42.86%
2021 1.291.351 49.05%
2022 1.134.543 -13.82%
2023 946.002 -19.93%
2024 1.204.954 21.49%

Procyon Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.59
Net Income per Share
-0.05
Price to Earning Ratio
-5.67x
Price To Sales Ratio
0.44x
POCF Ratio
22.47
PFCF Ratio
-17.21
Price to Book Ratio
0.94
EV to Sales
0.45
EV Over EBITDA
101.54
EV to Operating CashFlow
22.89
EV to FreeCashFlow
-17.53
Earnings Yield
-0.18
FreeCashFlow Yield
-0.06
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0.53
Graham NetNet
0.04

Income Statement Metrics

Net Income per Share
-0.05
Income Quality
-0.25
ROE
-0.15
Return On Assets
-0.11
Return On Capital Employed
-0.1
Net Income per EBT
1.99
EBT Per Ebit
0.74
Ebit per Revenue
-0.05
Effective Tax Rate
-0.99

Margins

Sales, General, & Administrative to Revenue
0.83
Research & Developement to Revenue
0.01
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.46
Operating Profit Margin
-0.05
Pretax Profit Margin
-0.03
Net Profit Margin
-0.07

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.01
Free CashFlow per Share
-0.02
Capex to Operating CashFlow
2.31
Capex to Revenue
0.05
Capex to Depreciation
0.82
Return on Invested Capital
-0.19
Return on Tangible Assets
-0.11
Days Sales Outstanding
36.84
Days Payables Outstanding
36.77
Days of Inventory on Hand
94.48
Receivables Turnover
9.91
Payables Turnover
9.93
Inventory Turnover
3.86
Capex per Share
0.03

Balance Sheet

Cash per Share
0,11
Book Value per Share
0,28
Tangible Book Value per Share
0.28
Shareholders Equity per Share
0.28
Interest Debt per Share
0.05
Debt to Equity
0.16
Debt to Assets
0.11
Net Debt to EBITDA
1.85
Current Ratio
2.9
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
2185751
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
533178
Debt to Market Cap
0.17

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Procyon Corporation Dividends
Year Dividends Growth

Procyon Corporation Profile

About Procyon Corporation

Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems primarily in the United States. The company offers advanced skin and wound care products, including the hydrogel wound dressing products, post op surgical kits, saline wound washes, care lotions, and barrier lotions to promote healing in wound and problematic skin conditions, as well as hand sanitizer under the AMERIGEL brand name. It also provides Bioactive Collagen products in the form of power and matrix under the HELIX3 brand name. In addition, the company offers wound care products, such as calcium alginate, foam, gauze, and hyrdocolloid dressing products; and wound care kits, which include calcium alginate, collagen matrix, collagen powder, foam, and hydrogel wound care kits under the AMERX brand name, as well as compression garment line products under the EXTREMIT-EASE name. It sells its products through distributors to institutional customers, such as hospitals, wound care clinics, nursing homes, home health agencies, physicians, and health care practitioners; and retail customers through direct sales, and internet sales, as well as through independent and retail chain drug stores. The company was incorporated in 1987 and is based in Clearwater, Florida.

CEO
Mr. Justice W. Anderson
Employee
19
Address
1300 South Highland Avenue
Clearwater, 33756

Procyon Corporation Executives & BODs

Procyon Corporation Executives & BODs
# Name Age
1 Mr. Justice W. Anderson
Chief Executive Officer, President & Director
70
2 Mr. James B. Anderson
Chief Financial Officer & Director
70
3 Mr. George Otis Borak
Vice President of Sales - Amerx Health Care Corporation
70

Procyon Corporation Competitors